Published in:
01-10-2019 | Molecular Imaging | Editorial
Current experts’ views on precision nuclear medicine imaging of phaeochromocytoma and paraganglioma
Authors:
David Taïeb, Karel Pacak
Published in:
European Journal of Nuclear Medicine and Molecular Imaging
|
Issue 11/2019
Login to get access
Abstract
The EANM/SNMMI 2019 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma (PPGL) describe the current experts’ views on molecular imaging in the era of precision medicine, and contain all of the information needed by nuclear physicians for performing, interpreting, and reporting the results of imaging investigations. This editorial, from a clinician’s perspective, describes the first-choice radiopharmaceutical for a particular clinical setting as an important element of the revised guidelines. It also gives new evidence-based data showing the steadily growing role of nuclear imaging in PPGL phenotyping and assessment of their clinical characteristics and outcomes.